Sekhmet Pharmaventures Private Limited’s Acquisition of Optimus Drugs, Optimus Pharma and Optimus Life Science

Khaitan & Co advised the targets Optimus Drugs Private Limited, Optimus Pharma Private Limited, and Optimus Life Science Private Limited, the promoter Mr Srinivasareddy Desireddy and the seller Unichem Laboratories Limited.

Sekhmet Pharmaventures Private Limited executed the acquisition of a stake in Optimus Drugs Private Limited, Optimus Pharma Private Limited, and Optimus Life Science Private Limited.

Optimus Drugs, Optimus Pharma and Optimus Life Science are engaged in the business of development and manufacturing of key starting materials (KSMs), intermediates and active pharmaceutical ingredients (APIs); and providing contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) services

The Khaitan & Co. team consisted of Lead Partner Bhavik Narsana (Picture), Vidur Sinha (Partner), Nirav Punjani (Senior Associate) and Stephanie Nazareth (Associate), Neil Lopez (Senior Associate), Zico Bahl (Associate), Ayesha Bhattacharya (Associate) and Anish Kapoor (Associate).

Involved fees earner: Zico Bahl – Khaitan & Co.; Ayesha Bhattacharya – Khaitan & Co.; Anish Kapoor – Khaitan & Co.; Neil Lopez – Khaitan & Co.; Bhavik Narsana – Khaitan & Co.; Stephanie Nazareth – Khaitan & Co.; Nirav Punjani – Khaitan & Co.; Vidur Sinha – Khaitan & Co.;

Law Firms: Khaitan & Co.;

Clients: Optimus Drugs ; Optimus Life Science Private Limited; Optimus Pharma;